Literature DB >> 3121792

Energy metabolism and quantal acetylcholine release: effects of botulinum toxin, 1-fluoro-2,4-dinitrobenzene, and diamide in the Torpedo electric organ.

Y Dunant1, F Loctin, J Marsal, D Muller, A Parducz, X Rabasseda.   

Abstract

In the Torpedo electric organ, a modified nerve-muscle system, type A botulinum toxin blocked the release of acetylcholine (ACh) quanta, both neurally evoked and spontaneous. At the same time, the toxin increased the release of a class of small miniature potentials (the subminiature potentials), reduced the ATP and more the creatine phosphate content of the tissue, and impaired the activity of creatine kinase (CK). Thus, we compared this pattern of changes with those provoked by 1-fluoro-2,4-dinitrobenzene (FDNB), an efficient inhibitor of CK. As expected, FDNB rapidly inactivated CK, which resulted in a profound depletion of ATP whereas the stores of creatine phosphate were preserved. In addition, FDNB caused conspicuous morphological alterations of nerve endings and ACh depletion. This agent also suppressed evoked and spontaneous quantal release whereas the occurrence of subminature potentials was markedly increased. Diamide, a penetrating thiol oxidizing substance, provoked first a transient rise in quantal ACh release and then blockade of transmission with, again, production of a large number of subminiature potentials. Creatine phosphate was depleted in the tissue by diamide, the ATP content reduced, and CK activity partly inhibited. The morphology of nerve terminals did not show obvious changes with either diamide or botulinum toxin at the stage of transmission failure. Although the three poisons acted by different mechanisms, this resulted in a rather similar pattern of physiological changes: failure of quantal release and enhancement of subquantal release. These results and experiments on synaptosomes indicated that CK inhibition was probably a crucial mechanism for FDNB but not for diamide or botulinum intoxication.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3121792     DOI: 10.1111/j.1471-4159.1988.tb02930.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

1.  Multiple GTP-binding proteins from cholinergic synaptic vesicles.

Authors:  J K Ngsee; K Miller; B Wendland; R H Scheller
Journal:  J Neurosci       Date:  1990-01       Impact factor: 6.167

Review 2.  Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis.

Authors:  T Wallimann; M Wyss; D Brdiczka; K Nicolay; H M Eppenberger
Journal:  Biochem J       Date:  1992-01-01       Impact factor: 3.857

Review 3.  Acetylcholine release and the cholinergic genomic locus.

Authors:  M Israël; Y Dunant
Journal:  Mol Neurobiol       Date:  1998-02       Impact factor: 5.590

Review 4.  In vitro reconstitution of neurotransmitter release.

Authors:  Y Dunant; M Israël
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

5.  Activation and desensitisation of acetylcholine release by zinc at Torpedo nerve terminals.

Authors:  Y Dunant; F Loctin; J P Vallée; A Parducz; B Lesbats; M Israël
Journal:  Pflugers Arch       Date:  1996-09       Impact factor: 3.657

6.  Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease.

Authors:  R T Matthews; L Yang; B G Jenkins; R J Ferrante; B R Rosen; R Kaddurah-Daouk; M F Beal
Journal:  J Neurosci       Date:  1998-01-01       Impact factor: 6.167

7.  Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease.

Authors:  R J Ferrante; O A Andreassen; B G Jenkins; A Dedeoglu; S Kuemmerle; J K Kubilus; R Kaddurah-Daouk; S M Hersch; M F Beal
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

Review 8.  Creatine kinase in non-muscle tissues and cells.

Authors:  T Wallimann; W Hemmer
Journal:  Mol Cell Biochem       Date:  1994 Apr-May       Impact factor: 3.396

9.  Creatine protects against excitoxicity in an in vitro model of neurodegeneration.

Authors:  Just Genius; Johanna Geiger; Andreas Bender; Hans-Jürgen Möller; Thomas Klopstock; Dan Rujescu
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

10.  Identification of an imidazoline binding protein: creatine kinase and an imidazoline-2 binding site.

Authors:  Atsuko Kimura; Robin J Tyacke; James J Robinson; Stephen M Husbands; Michael C W Minchin; David J Nutt; Alan L Hudson
Journal:  Brain Res       Date:  2009-05-03       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.